| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/16/2001 | CN1295472A Carbediolo-galenics |
| 05/16/2001 | CN1295470A Transdermal terapeutic system which contains D2 agonist and which is provided for treating parkinsonism, and method for production thereof |
| 05/16/2001 | CN1295469A Hydroxypylcellulose and anionic polymer compositions and their use as pharmaceutical film coatings |
| 05/16/2001 | CN1295468A Modified starch coating |
| 05/16/2001 | CN1295467A Biphasic controlled release delivery system for high solubility pharmaceuticals and method |
| 05/16/2001 | CN1295466A Process for manufacture of (sub) micron sized particles by dissolving in compressed gas and surfactants |
| 05/16/2001 | CN1295465A Quinolone-containing liposome composition |
| 05/16/2001 | CN1295464A Solid, quick dissolving cetirizine fomulation |
| 05/16/2001 | CN1295463A Fizzy formulation |
| 05/16/2001 | CN1295462A Peroral active agent suspension |
| 05/16/2001 | CN1295456A Acidified composition for topical treatment of nail and skin conditions |
| 05/16/2001 | CN1295146A Nonwoven fabric material with adhesive and pore |
| 05/16/2001 | CN1294926A Chinese medicine preparation for treating angina pectoris and its dispensation process |
| 05/16/2001 | CN1294921A Oil fragrance gas and its preparation |
| 05/16/2001 | CN1294912A Blood sugar reducing compound |
| 05/16/2001 | CN1294910A Acne and mite treating liniment |
| 05/16/2001 | CN1294903A Wound medicine moisture maintaining dressing |
| 05/16/2001 | CN1065762C Medical capsule for regulating insulin and reducing blood and/or uric sugar |
| 05/16/2001 | CN1065753C Hypoylycemic instant powder and prepn. thereof |
| 05/16/2001 | CN1065752C Sanzhufuzheng anticancer oral liquor and preparation method thereof |
| 05/16/2001 | CN1065751C Ledebouriella polysaccharide and its preparation |
| 05/16/2001 | CN1065748C Sea horse oral liquor and its preparing method |
| 05/16/2001 | CN1065744C Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor |
| 05/15/2001 | US6232366 Pressure sensitive conductive adhesive having hot-melt properties and biomedical electrodes using same |
| 05/15/2001 | US6232333 A solution in a organic solvent (mixture of ethanol and linoleic acid) of the hiv protease inhibitor (ritonavir), and a surfactant (polyoxyl 35 castor oil) optionally encapsulated in hard gelatin capsules or soft elastic capsules (sec) |
| 05/15/2001 | US6232330 Therapeutically effective amount of an insulin sensitivity enhancer(pioglitazone,troglitazone and salts) in combination with an aldose reductase inhibitor(tolurestat,epalrestat,imirestat,zenarestat) |
| 05/15/2001 | US6232301 Administering to the inside of a patient's bladder a solution of hyaluronic acid and/or its salts to promote vesical mucosa epithelium dilation |
| 05/15/2001 | US6232300 Administering as hepatitis b viricide |
| 05/15/2001 | US6231957 Rapidly disintegrating flavor wafer for flavor enrichment |
| 05/15/2001 | US6231900 Candy for treatment of cough and cold symptoms, coolants and flavors |
| 05/15/2001 | US6231892 Compositions for coating microcapsules and other surfaces |
| 05/15/2001 | US6231890 Suspension of sparingly water-soluble acidic drug |
| 05/15/2001 | US6231889 Unit dosage forms for the treatment of herpes simplex |
| 05/15/2001 | US6231888 Drug delivery for drugs with cores and coatings |
| 05/15/2001 | US6231887 Drugs of pyranone derivatives |
| 05/15/2001 | US6231886 Methods of providing sustained treatment with opioids |
| 05/15/2001 | US6231885 Composition for controlled and sustained transdermal administration |
| 05/15/2001 | US6231884 Plasters for antiischemic agents |
| 05/15/2001 | US6231882 Mixed micellar delivery system and method of preparation |
| 05/15/2001 | US6231881 Medium and matrix for long-term proliferation of cells |
| 05/15/2001 | US6231880 Antigrowth agents for cells by stimulating to patients and effective dimethyl substituted carboxylic acid |
| 05/15/2001 | US6231879 Implantable, biocompatible cell encapsulation with jackets |
| 05/15/2001 | US6231875 Acidified composition for topical treatment of nail and skin conditions |
| 05/15/2001 | US6231855 Side effect reduction |
| 05/15/2001 | US6231851 Methods and compositions for the dry powder formulation of interferons |
| 05/15/2001 | US6231848 N-vinyllactam homo or copolymer complexed with hydrogen peroxide and colloidal silver or silver salt useful as prophylaxis agent |
| 05/15/2001 | US6231845 Reducing irritation and redness of human skin caused by shaving comprising topically applying to shaved human skin an after shave clear solution or microemulsion containing water, ethanol, fragrance, surfactant and aluminum chlorohydrate |
| 05/15/2001 | US6231844 Nonionic surfactant foaming agents for foaming cosmetic compositions |
| 05/15/2001 | US6231835 Aerosol preparation for skin cooling |
| 05/15/2001 | US6231605 Frozen and thawed in mold to create interlocking mesh; expanded and immersed in water solution; human tissue replacement; biocompatibility |
| 05/15/2001 | US6231593 Patch, controller, and method for the photodynamic therapy of a dermal lesion |
| 05/15/2001 | CA2072355C Fibrin sealant delivery method |
| 05/15/2001 | CA2032068C Pharmaceutical lozenges |
| 05/10/2001 | WO2001033224A1 Composite particles, derived conjugates and their conjugates with biomolecules |
| 05/10/2001 | WO2001033223A1 Composite nanospheres and their conjugates with biomolecules |
| 05/10/2001 | WO2001032905A1 Process for producing a product containing antihypertensive tripeptides |
| 05/10/2001 | WO2001032852A2 Method for directed packaging of molecular substances in protein shells |
| 05/10/2001 | WO2001032836A1 Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| 05/10/2001 | WO2001032760A1 A porous, molecularly imprinted polymer and a process for the preparation thereof |
| 05/10/2001 | WO2001032751A1 Method for producing nanoparticulate chitosans or chitosan derivatives |
| 05/10/2001 | WO2001032730A1 Amphiphilic networks, implantable immunoisolatory devices, and methods of preparation |
| 05/10/2001 | WO2001032670A1 Oxetanone derivatives |
| 05/10/2001 | WO2001032630A1 Oligobenzimidazole derivatives and their use as dna transfection agents |
| 05/10/2001 | WO2001032616A2 Oxetanone derivatives |
| 05/10/2001 | WO2001032596A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 05/10/2001 | WO2001032237A1 Method and device for preparing a medical fluid |
| 05/10/2001 | WO2001032232A2 Method of forming micropores in skin |
| 05/10/2001 | WO2001032230A2 A polymer micelle as monolayer or layer-laminated surface |
| 05/10/2001 | WO2001032222A1 Selective toxin expression in angiogenic endothelial cells |
| 05/10/2001 | WO2001032220A1 Gene therapy for diabetic ischemic disease |
| 05/10/2001 | WO2001032218A1 Compositions and methods for controlled-release delivery and increased potency of pharmaceuticals via hydrophobic ion-pairing |
| 05/10/2001 | WO2001032217A2 Pharmacological inducement of the fed mode for enhanced drug administration to the stomach |
| 05/10/2001 | WO2001032212A1 Drugs, drinks or foods |
| 05/10/2001 | WO2001032208A1 Adjuvanted genetic vaccines |
| 05/10/2001 | WO2001032205A1 Mucosal preventives for mastitis |
| 05/10/2001 | WO2001032204A2 Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression |
| 05/10/2001 | WO2001032190A1 Antiviral composition comprising an extraction product of fava b eans |
| 05/10/2001 | WO2001032185A1 A pharmaceutical composition containing bisphosphonic acid(s) or salt(s) thereof and a process of preparing thereof |
| 05/10/2001 | WO2001032183A2 Pharmaceutical compositions comprising oxcarbazepine |
| 05/10/2001 | WO2001032181A2 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum |
| 05/10/2001 | WO2001032180A2 Composition for treatment of constipation and irritable bowel syndrome |
| 05/10/2001 | WO2001032172A1 Process for formulation of carbapenem antibiotic compositions |
| 05/10/2001 | WO2001032166A1 NEW COMBINATION COMPRISING A β2-ADRENORECEPTOR AGONIST AND A LEUKOTRIENE RECEPTOR ANTAGONIST |
| 05/10/2001 | WO2001032165A1 Method for administering a phosphodiesterase 4 inhibitor |
| 05/10/2001 | WO2001032163A1 NEW COMBINATION COMPRISING A BETA 2 (β)2 ADRENO RECEPTOR AGONIST AND A LENKOTRIENE RECEPTOR ANTAGONIST |
| 05/10/2001 | WO2001032162A1 Liver selective therapy |
| 05/10/2001 | WO2001032161A2 Use of a hmg-coa reductase inhibitor for treating amyloid beta precursor disorders |
| 05/10/2001 | WO2001032158A2 Pharmaceutical composition comprising a combination of metformin and another antidiabetic agent |
| 05/10/2001 | WO2001032157A2 Pharmaceutical composition comprising a combination of metformin and glibenclamide |
| 05/10/2001 | WO2001032152A1 Edible mcc/pga coating composition |
| 05/10/2001 | WO2001032151A1 Acid coatings facilitating deglutition |
| 05/10/2001 | WO2001032150A1 Edible coating composition |
| 05/10/2001 | WO2001032149A1 Osmotic controlled release drug delivery device |
| 05/10/2001 | WO2001032148A1 Controlled release hydrocodone formulations |
| 05/10/2001 | WO2001032146A2 Amphiphilic polymeric vesicles |
| 05/10/2001 | WO2001032145A1 Method of cancer treatment |
| 05/10/2001 | WO2001032144A1 Dry powder compositions having improved dispersivity |
| 05/10/2001 | WO2001032143A1 A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and a process for preparation thereof |
| 05/10/2001 | WO2001032142A1 Cyclosporin formulation |
| 05/10/2001 | WO2001032140A1 Ocular insert |